Ron Ferguson

USPTO Granted Patents = 14 (Patent Applications = 2)

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 56(Granted Patents)

Location History:

Milan, IT (2013)
Scotch Plains, NJ (US) (2012 - 2016)
Casale Litta, IT (2009 - 2019)

Company Filing History:

13 out of 138

Nerviano Medical Sciences S.r.l.

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 2009-2019

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10280176 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2019-05-07),

2. 9637497 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2017-05-02),

3. 9464090 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2016-10-11),

4. 9226922 - Compounds that are ERK inhibitors (2016-01-05),

5. 8993556 - Resorcinol derivatives as HSP90 inhibitors (2015-03-31),

6. 8981092 - Substituted 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-ones as modulators of protein kinase activity (2015-03-17),

7. 8981089 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2015-03-17),

8. 8623876 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2014-01-07),

9. 8614220 - Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2013-12-24),

10. 8541429 - Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2013-09-24),

11. 8394802 - 3,4-dihydro-2H-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases (2013-03-12),

12. 8309578 - Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents (2012-11-13),

13. 8227472 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2012-07-24),

14. 7482354 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2009-01-27),

Title: The Innovative Journey of Ron Ferguson

Introduction: Ron Ferguson, a visionary inventor hailing from Casale Litta, Italy, has made significant contributions to the world of technology through his groundbreaking inventions.

Latest Patents: Ron Ferguson's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry and a sustainable energy solution that aims to combat climate change.

Career Highlights: With over two decades of experience in the tech industry, Ron Ferguson has a proven track record of turning innovative ideas into reality. He has worked for leading tech companies and research institutions, honing his skills and pushing the boundaries of what is possible.

Collaborations: Throughout his career, Ron Ferguson has collaborated with top engineers, designers, and scientists from around the globe. These collaborations have led to the development of groundbreaking technologies that have changed the way we live and work.

Conclusion: Ron Ferguson's passion for innovation and his relentless drive to push the limits of technology make him a true pioneer in the field of inventions. His work continues to inspire the next generation of inventors to dream big and create a better future for all.

This text is generated by artificial intelligence and may not be accurate.